Clinical trial
Safety and Efficacy of Targeted Gene Transfer in Colorectal Cancer Metastatic to…
NCT00035919 · University of Southern California, Other · Withdrawn
Key facts
| NCT number | NCT00035919 |
|---|---|
| Title | Safety and Efficacy of Targeted Gene Transfer in Colorectal Cancer Metastatic to Liver |
| Official title | Tumor Site Specific Phase I Evaluation of Safety of Hepatic Arterial Infusion of a Matrix-Targeted Retroviral Vector Bearing a Dominant Negative Cyclin G1 Construct as Intervention for Colorectal Carcinoma Metastatic to Liver |
| Lead sponsor | University of Southern California, Other |
| Status | Withdrawn |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Neoplasms |
| Intervention type | Genetic |
| Interventions | Mx-dnG1 Retroviral Vector |
| Enrollment | 0 |
| Start date | Nov 1, 2002 |
| Completion | Oct 1, 2003 |
| First posted | May 7, 2002 |
| Last update posted | May 22, 2014 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: